Expression of Nuclear Factor-κB, Tumor Necrosis Factor Receptor Type 1, and c-Myc in Human Astrocytomas
-
- HAYASHI Shuji
- Department of Neurosurgery, Fukuoka University School of Medicine
-
- YAMAMOTO Masaaki
- Department of Neurosurgery, Fukuoka University School of Medicine Molecular Oncology Center, Fukuoka University School of Medicine
-
- UENO Yushi
- Department of Neurosurgery, Fukuoka University School of Medicine
-
- IKEDA Kohichi
- Department of Neurosurgery, Fukuoka University School of Medicine
-
- OHSHIMA Koichi
- Department of Pathology, Fukuoka University School of Medicine
-
- SOMA Gen-Ichiro
- Institute for Health Sciences, Tokushima Bunri University
-
- FUKUSHIMA Takeo
- Department of Neurosurgery, Fukuoka University School of Medicine
書誌事項
- タイトル別名
-
- Expression of Nuclear Factor-κB, Tumor Necrosis Factor Receptor Type 1, and c-Myc in Human Astrocytomas
この論文をさがす
抄録
Tumor necrosis factor receptor type 1 (TNFR1) and c-Myc are important in signal transduction in tumor necrosis factor-α (TNF-α)-induced cytotoxicity, whereas activation of nuclear factor-κB (NF-κB) protects against TNF-α-induced apoptosis. This study investigated the expression of NF-κB, TNFR1, and c-Myc in human astrocytoma tissues by reverse transcriptase-polymerase chain reaction (PCR) and immunohistochemical analysis. TNFR1 messenger ribonucleic acid (mRNA) and c-Myc mRNA were frequently expressed in malignant astrocytomas, especially in glioblastomas, compared with low-grade astrocytomas by PCR analysis. TNFR1 and c-Myc mRNAs were barely detectable in normal brain tissues. NF-κB p50 and p65 subunit mRNAs were detected in various grades of astrocytomas, with frequent expression in malignant astrocytomas. The presence of activated NF-κB was confirmed by nuclear localization in neoplastic astrocytes as determined by immunohistochemistry. Both p50 and p65 subunits were inhomogeneously expressed in neoplastic astrocytes of glioblastoma, but only in a few scattered tumor cells in low-grade astrocytoma, and almost undetectable in normal brain tissues. These results indicate that TNFR1 and c-Myc are overexpressed in malignant astrocytomas, and this may increase the cellular sensitivity to the cytotoxic action of TNF-α. NF-κB p50 and p65 were simultaneously induced and activated in malignant astrocytomas. Our results suggest that the constitutive activation of NF-κB subunits in malignant astrocytoma, especially in glioblastoma, could be associated with the resistance to TNF-α immunotherapy, and indicates new therapeutic strategies for malignant astrocytomas.<br>
収録刊行物
-
- Neurologia medico-chirurgica
-
Neurologia medico-chirurgica 41 (4), 187-195, 2001
一般社団法人 日本脳神経外科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205048423680
-
- NII論文ID
- 110002281355
-
- NII書誌ID
- AN00358613
-
- COI
- 1:STN:280:DC%2BD3M3psVymtg%3D%3D
-
- ISSN
- 13498029
- 04708105
-
- PubMed
- 11381677
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可